Article · 29 Aug 2026
Conference abstract
Advancing Th1 stimulatory proteins towards development of polypeptide vaccine against Kalaazar
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Visceral leishmaniasis (VL), a fatal disease affecting millions of individual on global scenario, is the second major life threatening parasitic disease in the world, after Malaria. The disease is prevalent mainly in the region of tropical, subtropical and the Mediterranean countries. Immune response, in particular cell mediated (CMI), is severely suppressed during active VL and the resolution of the parasites relies on its up-regulation. Available treatment for VL bears problems related to toxicity, adverse effects, cost effectiveness etc. Emergence of drug resistance cases poses another major threat to Kala-azar control program. Therefore, vaccine against VL offers viable alternative since the recovered individuals possess life-long protection against re-infection. Amongst various approaches for vaccine development, immune-informatics offers new area for the development of effective vaccine against VL. Defining antigenic portions of protein capable of eliciting a protective immune response is crucial in the development of epitope-based vaccine strategies. Artificial neural network (ANN), support vector machine (SVM) and Hidden Markov Model (HMM) helps in generating new epitope mapping algorithms for predicting novel antigenic sites of a protein which can further be validated for specific triggering of both humoral and cell-mediated immune responses. This talk focuses on the various approaches utilized for the identification of new and potentially vital Leishmania Th1 stimulatory proteins/peptides as vaccine entities which further lead to the designing of polypeptide vaccine. This new vaccine approach to treating VL expands host protective immune responses; making the host produce beneficial T-cells that reduce parasite burden and alleviate disease symptoms more quickly.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Anuradha Dube”
- BylineArticles whose byline prints “Sumit Joshi”
- BylineArticles whose byline prints “Narendra K Yadav”
- BylineArticles whose byline prints “Keerti Rawat”